Barely Significant
← all excerpts

Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trial.

Lancet Glob Health · 2025 · PMC11950424 · PMID 40155105

1
hedged sentence
closest p
boldest claim

The sentences

might be significantno p-value reported
In small countries, such as Guatemala or Zambia, these might be significant compared with the costs or cost savings.

also in 2,457 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.